Profile data is unavailable for this security.
About the company
CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.
- Revenue in HKD (TTM)656.98m
- Net income in HKD-934.16m
- Incorporated2009
- Employees1.49k
- LocationCanSino Biologics IncWest District Biomedical Park, No. 185South Avenue, West District, EconomicTIANJIN 300457ChinaCHN
- Phone+86 2 258213766
- Fax+86 2 258213626
- Websitehttp://www.cansinotech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Yichang Hec Changjiang Pharmactcl Co Ltd | 5.97bn | 1.78bn | 7.90bn | 4.89k | 4.45 | 0.846 | 3.83 | 1.32 | 2.02 | 2.02 | 6.79 | 10.61 | 0.4272 | 2.50 | 3.74 | 1,293,143.00 | 11.69 | 8.03 | 17.27 | 11.81 | 78.90 | 79.97 | 27.37 | 20.80 | 1.93 | 50.79 | 0.2126 | 15.81 | 68.08 | 20.18 | 2,501.24 | 16.15 | -11.50 | -- |
| AIM Vaccine Co Ltd | 1.28bn | -1.28bn | 9.80bn | 1.56k | -- | 2.59 | -- | 7.68 | -1.06 | -1.06 | 1.05 | 3.12 | 0.1462 | 0.6325 | 1.10 | 785,948.40 | -22.69 | -- | -37.16 | -- | 72.34 | -- | -155.22 | -- | 0.6836 | -6.61 | 0.3437 | -- | -6.06 | -- | -307.07 | -- | -- | -- |
| Beijing Biostar Pharmaceuticals Co Ltd | -100.00bn | -100.00bn | 10.37bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 103.03 | -- | -18.15 | -- | -- | -- |
| Luye Pharma Group Ltd | 6.81bn | 830.46m | 10.50bn | 5.23k | 12.64 | 0.7479 | 6.28 | 1.54 | 0.2208 | 0.2208 | 1.81 | 3.73 | 0.236 | 2.44 | 3.02 | 1,291,299.00 | 3.11 | 2.80 | 5.47 | 4.45 | 68.73 | 70.53 | 13.18 | 10.39 | 1.20 | 3.14 | 0.4103 | 11.82 | 2.70 | 3.50 | -11.94 | -16.39 | -14.05 | -- |
| Shanghai Henlius Biotech Inc | 6.08bn | 746.25m | 11.14bn | 3.55k | 14.97 | 4.01 | 9.74 | 1.83 | 1.37 | 1.37 | 11.14 | 5.11 | 0.5764 | 1.90 | 6.82 | 1,671,636.00 | 7.07 | -8.59 | 14.25 | -14.14 | 73.23 | 71.77 | 12.27 | -27.37 | 0.329 | 7.60 | 0.6113 | -- | 67.82 | 273.51 | 178.53 | -- | 49.14 | -- |
| SSY Group Ltd | 6.47bn | 1.37bn | 11.45bn | 5.80k | 8.43 | 1.58 | 6.26 | 1.77 | 0.4593 | 0.4593 | 2.18 | 2.44 | 0.5418 | 2.75 | 3.07 | 1,155,141.00 | 11.54 | 10.51 | 14.88 | 14.03 | 54.39 | 58.72 | 21.30 | 18.62 | 2.06 | 28.65 | 0.323 | 38.56 | 0.4505 | 9.10 | 17.44 | 7.66 | 3.94 | 13.56 |
| China Traditional Chinese Med Hldg CoLtd | 18.54bn | 988.87m | 11.78bn | 17.72k | 11.92 | 0.5116 | 5.23 | 0.6355 | 0.1964 | 0.1964 | 3.68 | 4.57 | 0.453 | 1.54 | 1.82 | 1,071,720.00 | 2.62 | 4.60 | 4.01 | 7.07 | 49.86 | 57.07 | 5.77 | 9.77 | 1.51 | 7.39 | 0.1808 | 17.35 | 26.69 | 9.99 | 68.11 | -2.24 | -12.75 | -- |
| Everest Medicines Ltd | 451.14m | -1.14bn | 11.81bn | 520.00 | -- | 2.45 | -- | 26.19 | -3.52 | -3.52 | 1.40 | 14.82 | 0.0756 | 5.23 | 3.22 | 1,044,315.00 | -19.03 | -30.52 | -20.21 | -33.14 | 75.74 | -- | -251.64 | -5,745.25 | 4.62 | -- | 0.1119 | -- | 884.46 | -- | -241.50 | -- | 4.65 | -- |
| Cansino Biologics Inc | 656.98m | -934.16m | 12.96bn | 1.49k | -- | 1.49 | -- | 19.73 | -3.79 | -3.79 | 2.66 | 22.08 | 0.0676 | 1.28 | 0.8385 | 439,742.40 | -10.15 | -4.27 | -13.73 | -5.60 | 14.38 | -- | -150.19 | -27.72 | 2.19 | -- | 0.3028 | -- | -66.52 | 213.94 | -63.04 | -- | 30.60 | -- |
| 3SBio Inc | 9.08bn | 1.79bn | 13.99bn | 5.61k | 7.96 | 0.9023 | 6.31 | 1.54 | 0.7339 | 0.7339 | 3.73 | 6.47 | 0.3575 | 1.52 | 6.87 | 1,677,561.00 | 7.25 | 7.44 | 10.26 | 9.29 | 85.94 | 82.91 | 20.27 | 21.50 | 1.57 | 141.55 | 0.1998 | -- | 13.84 | 11.26 | -19.13 | 3.94 | 8.78 | -- |
| Simcere Pharmaceutical Group Ltd | 6.84bn | -1.19bn | 16.47bn | 6.41k | -- | 2.23 | -- | 2.41 | -0.4543 | -0.4543 | 2.65 | 2.93 | 0.5198 | 2.19 | 2.64 | 972,792.20 | -9.04 | 10.17 | -11.71 | 15.60 | 77.02 | 78.82 | -17.40 | 17.50 | 1.88 | 0.4721 | 0.1461 | 46.68 | 4.49 | 7.92 | -23.22 | -0.5213 | 23.93 | -- |
| Grand Pharmaceutical Group Ltd | 10.59bn | 2.41bn | 17.32bn | 10.78k | 7.09 | 1.10 | 6.02 | 1.64 | 0.6885 | 0.6885 | 3.03 | 4.43 | 0.4472 | 3.62 | 4.54 | 1,005,064.00 | 10.25 | 10.09 | 14.21 | 14.01 | 59.00 | 61.97 | 22.92 | 22.35 | 1.09 | -- | 0.2232 | 26.94 | 10.12 | 12.06 | -9.59 | 21.41 | 5.69 | 24.77 |
| The United Laboratories Intl. Hldgs Ltd. | 15.10bn | 3.13bn | 18.42bn | 15.00k | 5.88 | 1.26 | 4.92 | 1.22 | 1.73 | 1.73 | 8.31 | 8.02 | 0.6578 | 3.30 | 5.67 | 1,006,664.00 | 13.65 | 7.89 | 20.72 | 12.64 | 46.15 | 44.17 | 20.75 | 12.73 | 1.72 | -- | 0.1532 | 28.99 | 21.22 | 12.84 | 70.85 | 31.66 | 24.19 | 46.04 |
Data as of Nov 13 2024. Currency figures normalised to CanSino Biologics Inc's reporting currency: Hong Kong Dollar HKD
6.85%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 02 Oct 2024 | 3.28m | 2.47% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 1.31m | 0.99% |
| BlackRock Fund Advisorsas of 03 Oct 2024 | 896.20k | 0.68% |
| Capital Research & Management Co. (World Investors)as of 30 Sep 2024 | 893.52k | 0.67% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2024 | 621.80k | 0.47% |
| HSBC Jintrust Fund Management Co. Ltd.as of 30 Jun 2024 | 572.20k | 0.43% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 496.00k | 0.37% |
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 401.60k | 0.30% |
| BlackRock Advisors (UK) Ltd.as of 03 Oct 2024 | 381.60k | 0.29% |
| CSOP Asset Management Ltd.as of 03 Oct 2024 | 232.41k | 0.18% |
More ▼
Data from 30 Jun 2024 - 29 Oct 2024Source: FactSet Research Systems Inc.
